Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

Stockholders' Equity
3 Months Ended
Sep. 30, 2020
Disclosure Text Block Supplement [Abstract]  
Stockholders' Equity

Note 11. Stockholders’ Equity

Equity Issuances

On May 8, 2020, the Company entered into an ATM Equity OfferingSM Sales Agreement with BofA Securities, Inc. and Piper & Sandler & Co. pursuant to which the Company may sell from time to time shares of its common stock having an aggregate offering price of up to $50,000,000 (the “ATM Program”). 

During the three months ended September 30, 2020, the Company sold a total of 416,221 shares of its common stock at a price to the public of an average of $8.08 per share through the ATM Program for aggregate gross proceeds of approximately $3.4 million, before deducting compensation paid to the sales agents of approximately $0.1 million. 

Equity Incentive Plans

During the three months ended September 30, 2020, the Company granted employees options to purchase an aggregate of 356,750 shares of common stock with a weighted average grant date fair value of $4.48. The fair values of the Company’s options were estimated at the dates of grant using a Black-Scholes option pricing model with the following assumptions:


Three Months
September 30,

Exercise price   $ 7.72 - 8.14  
Expected term (years)   4.75 – 5.00  
Risk-free interest rate   0.25% – 0.28%  
Volatility   67 - 68%  
Dividend yield   0%
Weighted Average Grant Date Fair Value of Options granted during the period   $4.48  

Expected term: The Company’s expected term is based on the period the options are expected to remain outstanding. The Company estimated this amount utilizing the “Simplified Method” in that the Company does not have sufficient historical experience to provide a reasonable basis to estimate an expected term.

Risk-free interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Note with a similar term on the date of the grant.

Volatility: The Company calculates the expected volatility of the stock price using the historical volatilities of the Company’s common stock traded on the Nasdaq Capital Market.

Dividend yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in the near future.

During the three months ended September 30, 2020 the Company awarded certain employees and directors grants of an aggregate of 407,403 restricted stock units (“RSUs”) with a weighted average grant date fair value of $8.07. The RSUs will be expensed over the requisite service period. The terms of the RSUs include vesting provisions based solely on continued service. If the service criteria are satisfied, the RSUs will generally vest over 4 – 5 years.

Compensation expense related to our stock-based awards described above was as follows (in thousands):

    Three Months Ended  September 30,  
    2020     2019  
Research and Development   $ 1,014     $ 956  
General and Administrative     1,013       747  
Total   $ 2,027     $ 1,703  

Unrecognized stock-based compensation expense and weighted-average years to be recognized are as follows (in thousands):

    As of September 30, 2020  

Unrecognized stock-  


to be recognized
Options   $ 3,257       2.39  
Restricted stock awards/units   $ 8,267       2.40